Consumer Staples · Household Products · US stock · price as of 16 Oct 2026
Key indicators
Price
$87.09
52-week range
$79.12 – $125.83
Market cap
$10.6B
P/E (trailing)
17.7×
EV / EBITDA
–
Free-cash-flow yield
–
Dividend yield
5.7%
Revenue (last 12 months)
–
Revenue growth (3y a year)
–
Operating margin
–
Return on invested capital
–
Net debt / EBITDA
–
Fair value
Blended fair value$118.73 book-value models
Versus priceFair+36% to fair value
Peer multiples
$118.73
Model uncertainty
High
X-Ray Score
36/ 100 · Low confidence · ahead of 17% of sector peers
Valuation64
Growth22
Profitability16
Financial health–
Dividends44
Five-year price chart navy: price · brown: 200-day average · blue band: fair value range
Executive summary
Clorox makes and markets consumer and professional products for the home, including Clorox bleach and disinfecting products, Pine-Sol, Burt's Bees, Fresh Step cat litter, Hidden Valley salad dressings and Kingsford charcoal. Customers are mass merchandisers, grocery chains, club stores, online retailers and institutional customers. It is based in Oakland, California.
Clorox earns revenue from cleaning, household, wellness and lifestyle products that reach shoppers mainly through retailers. The data sheet carries few financial figures for the company at present, but it shows that Clorox pays a dividend with a yield of 5.7%.
StocksXray gives Clorox Co an X-Ray Score of 36 out of 100 (low confidence), ahead of 17% of the S&P 500 stocks in its sector. Its strongest lens is valuation (64) and its weakest is profitability (16).
Our fair value blend is $118.73. At $87.09 the stock trades 27% below that blend, so the label is "Fair" with high model uncertainty. Fair value is a range, not a price target.
XStocksXray
Clorox Co (CLX)
Valuation history multiples at each fiscal year-end price; the last column uses today's price and the last twelve months
FY2022
FY2023
FY2024
FY2025
FY2026
Now
Price
$120.83
$140.74
$124.95
$113.56
$94.34
$87.09
Market cap
$15.0B
$17.5B
$15.6B
$14.1B
–
$10.6B
P/E
32.4×
117.3×
55.5×
17.4×
–
17.7×
EV / revenue
2.5×
2.7×
2.5×
2.3×
–
–
EV / EBITDA
18.9×
35.1×
25.0×
12.0×
–
–
Price / free cash flow
28.0×
18.8×
32.3×
18.5×
–
–
Free-cash-flow yield
3.6%
5.3%
3.1%
5.4%
–
–
Price / book
26.9×
79.4×
47.5×
44.0×
–
–
Dividend yield
2.88%
3.35%
3.84%
4.30%
–
5.71%
Fundamentals checklist ● 0 Good · ● 1 Average · ● 1 Bad · each check graded against the sector
Growth
Growth consistency33%Bad
Valuation
Fair value vs price1.4×Average
XStocksXray
Clorox Co (CLX)
Financials US$ millions, from SEC filings; last column is the last twelve months
Income statement
FY22
FY23
FY24
FY25
FY26
LTM
Revenue
7,107
7,389
7,093
7,104
–
–
Gross profit
2,545
2,908
3,048
3,213
–
–
Operating income
713
328
488
1,166
–
–
Net income
471
161
292
824
601
601
Diluted EPS ($)
3.73
1.20
2.25
6.52
–
4.92
Free cash flow
535
930
483
761
–
–
Gross margin
35.8%
39.4%
43.0%
45.2%
–
–
Operating margin
10.0%
4.4%
6.9%
16.4%
–
–
Net margin
6.6%
2.2%
4.1%
11.6%
–
–
Balance sheet
FY22
FY23
FY24
FY25
FY26
LTM
Total assets
6,158
5,945
5,751
5,561
–
–
Cash
183
367
202
167
–
–
Total debt
2,711
2,527
2,485
2,488
–
–
Equity
556
220
328
321
–
–
Dividend per share ($)
3.48
4.72
4.80
4.88
–
–
Revenue and net income US$ billions: navy revenue, teal net income
Every number comes from SEC filings, end-of-day prices and the StocksXray models described on the methodology page. The X-Ray Score ranks each metric against the company's own sector. Fair value blends three models and carries a typical error of about 40%, so treat it as a range. Analyst ratings, price targets and earnings-call summaries are not part of this report. Educational research, not financial advice; read the disclaimer.